id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
3232404,dd0f4f46-dcce-4e2e-87e7-fb9ecb0a5bca,Q3,2359 STRATEGIES,401106114,TRAVERE THERAPEUTICS,2024,third_quarter,HCR,Rare kidney disease,"HOUSE OF REPRESENTATIVES,SENATE",12000,,0,0,2024-10-03T18:25:31-04:00